The AltiGen Communications (OTCQX: ATGN) chart looks to have found a bottom at 20 cents in December and is putting together a solid uptrend as the indicators are shifting from bearish to bullish. Some resistance is set at 35 cents, but solid support is nearby as the moving averages are curling underneath the price per share giving the chart a very solid appeal. Officially a Pink Sheet stock, the company is actually listed on OTC Markets on their OTCQX tier, their highest tier with standards similar to NASDAQ’s continued listing requirements.

The company recently released news that it is expanding its global footprint by partnering with Eurodata Systems Ltd, a well-established Information Technology services provider to the UK’s public and private sector, to deliver AltiGen’s MaxACD contact center solution for Microsoft Lync™.

This is a relatively quiet and certainly “under the radar” company with an incredibly tight share structure, solid revenue and a tiny market cap; qualifying by our standards as a substantially undervalued company. Do your due diligence on this one.

AltiGen Communications, Inc. is a leading provider of 100% Microsoft-based VoIP business phone systems and Unified Communications solutions. Having more than 10,000 customers around the world, AltiGen solutions are designed for high reliability, ease of use, seamless integration to Microsoft infrastructure technologies, and are built on a scalable, open standards platform. AltiGen’s worldwide headquarters is in Silicon Valley, California, with international operations based in Shanghai, China. Local sales, service and support are provided by AltiGen’s worldwide network of over 300 certified partners.

AltiGen Communications (ATGN) Stock Quote and News:

---

Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/about-2/disclaimer.